Lo Re, V, Fox, K, Ferrari, V, Kossev, P, and Kostman, J.: Hypereosinophilia associated with Cardiac Rhabdomyosarcoma, accepted for publication American Journal of Hematology : 2003.
Santiago, J, Wu, L, Harris, E, Fox, K, Schultz, D, Glick, J, and Solin, L.: Fifteen year results of breast conserving surgery and definitive irradiation for stage I and II breast carcinoma: The University of Pennsylvania experience. Submitted : 2003.
Manne, S, Ostroff, J, Sherman, M, Glassman, M, Ross, S, Goldstein, L, Fox, K.: Buffering effects for family and friend support on associations between partner unsupportive behaviors and coping among women with breast cancer. Accepted for publication, J Soc Pers Rel
Santiago, R, Wu, L, Schultz, D, Harris, E, Fox, K, Glick, J, Solin, L.: Fifteen-year results of breast-conserving surgery and definitive irradiation for stage I and II breast cancer: the University of Pennsylvania experience. Proc ASCO
21 : 39a,2002.
Miller, W., DeMichele, A, Fox, K, Glick, J, Batist, G, Welles, L.: A phase I/II dose escalating trial of liposomal doxorubicin (TLC D-99, Myocet) in combination with
paclitaxel (Taxol, T) for patients (pts) wit metastatic breast cancer (MBC). Proc ASCO
21 : 31b,2002.
Moore, HCF, and Fox, K.: Hormonal therapy. Breast Cancer: A multidisciplinary approach. : 161-174,2002.
Fox, K: Ascites. Clinical Practice of Hematology and Oncology : 2002.
Chang, J, Vines, E, Bertsch, H, Fraker, D, Czerniecki, B, Rosato, E, Tomaszewski, J, Conant, E, Orel, S, Schuchter, L, Fox, K, Zieber, N, Glick, J, Solin, L.: The impact Of a multidisciplinary breast cancer clinic on patient management decisions: The University of Pennsylvania experience. Cancer 91 : 1231-1237,2001.
Fox, KR, Ball, J, Mick, R, and Moore, HC.: Preventing chemotherapy-associated amenorrhea (CRA) with leuprolide in young women with early-stage breast cancer.
Proc ASCO 20 : 25a,2001.
Ball, J, and Fox, KR.: Age-associated incidence of chemotherapy-related amenorhea (CRA) following adjuvant doxorubicin, cyclophosphamide, and paclitaxel (AC/TAXOL) in early-stage breast cancer. Proc ASCO 20 : 16b,2001.